The Current Role of Bevacizumab in the Treatment of Hereditary Hemorrhagic Telangiectasia-Related Bleeding
- PMID: 29395348
- DOI: 10.1016/j.mayocp.2017.12.019
The Current Role of Bevacizumab in the Treatment of Hereditary Hemorrhagic Telangiectasia-Related Bleeding
Comment on
-
Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding.Mayo Clin Proc. 2018 Feb;93(2):155-166. doi: 10.1016/j.mayocp.2017.11.013. Epub 2018 Jan 24. Mayo Clin Proc. 2018. PMID: 29395350
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources